Responses
Poster Presentations
Rheumatoid arthritis - non biologic treatment
THU0205 Effects of the jak1-selective inhibitor filgotinib on multibiomarker disease activity scores in patients with active rheumatoid arthritis and an inadequate response to methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.